Matthieu Prot
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Vectors
- Virology top 5%
Papers in
-
- RNA Interference and Gene Delivery 3
-
- Viral Infections and Vectors 5
- SARS-CoV-2 and COVID-19 Research 5
- Co-authors
- Bernard Binétruy (6 shared papers)Myriam Aouadi (5 shared papers)Frédéric Bost (4 shared papers)Y. Le Marchand‐Brustel (4 shared papers)Etienne Simon‐Lorière (21 shared papers)Leslie Caron (3 shared papers)Paul Hofman (2 shared papers)Kathiane Laurent (1 shared paper)
- Journals
- Journal of Virology (2 papers)Nature Communications (2 papers)International Journal of Antimicrobial Agents (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Diabetes (2 papers)
- Partner nations
- FranceUnited StatesCambodia
In The Last Decade
Matthieu Prot
34 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Infectious Diseases 368
- Virology 86
- Emergency Medicine 124
- Biochemistry 110
- Molecular Biology 708
Countries citing papers authored by Matthieu Prot
This map shows the geographic impact of Matthieu Prot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Prot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Prot more than expected).
Fields of papers citing papers by Matthieu Prot
This network shows the impact of papers produced by Matthieu Prot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Prot. The network helps show where Matthieu Prot may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthieu Prot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 281 | |
| 2 | 2006 | 164 | |
| 3 | 2007 | 150 | |
| 4 | 2021 | 135 | |
| 5 | 2016 | 111 | |
| 6 | 2009 | 111 | |
| 7 | 2011 | 100 | |
| 8 | 2016 | 94 | |
| 9 | 2019 | 71 | |
| 10 | 2010 | 66 | |
| 11 | 2020 | 52 | |
| 12 | 2005 | 34 | |
| 13 | 2006 | 29 | |
| 14 | 2020 | 26 | |
| 15 | 2019 | 24 | |
| 16 | 2018 | 23 | |
| 17 | 2020 | 21 | |
| 18 | 2022 | 21 | |
| 19 | 2020 | 20 | |
| 20 | 2024 | 19 |
About Matthieu Prot
Matthieu Prot is a scholar working on Molecular Biology, Infectious Diseases, Public Health, Environmental and Occupational Health, Epidemiology and Physiology, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (12 papers), Viral Infections and Vectors (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), RNA Interference and Gene Delivery (3 papers), Malaria Research and Control (3 papers), Adipose Tissue and Metabolism (3 papers), HIV-related health complications and treatments (3 papers) and Lipid metabolism and biosynthesis (2 papers). The work is most often cited by research in Infectious Diseases (368 citations), Virology (86 citations), Emergency Medicine (124 citations), Biochemistry (110 citations) and Molecular Biology (708 citations). Matthieu Prot has collaborated with scholars based in France, United States and Cambodia. Frequent co-authors include Bernard Binétruy, Myriam Aouadi, Frédéric Bost, Y. Le Marchand‐Brustel, Etienne Simon‐Lorière, Leslie Caron, Paul Hofman, Kathiane Laurent, Christian Dani and Jacques Pouysségur. Their work appears in journals such as Journal of Virology, Nature Communications, International Journal of Antimicrobial Agents, Antimicrobial Agents and Chemotherapy and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.